Loss of ras oncogene mutation in a myelodysplastic syndrome after low-dose cytarabine therapy.
Layton
D M
DM
Mufti
G J
GJ
Lyons
J
J
Janssen
J W
JW
Bartram
C R
CR
D003561:Cytarabine / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D011905:Genes, ras; D006801:Humans; D008875:Middle Aged; D009154:Mutation; D009190:Myelodysplastic Syndromes / Q000188:drug therapy / Q000235:genetics*
D003561:Cytarabine